Aidoc has raised $150 million in Series E funding led by Goldman Sachs to enhance its clinical AI capabilities. The investment aims to improve diagnostic efficiency across health systems.
PRIVATEApr 29, 2026
Amount Raised
$150 Million
Round Type
Series E
New YorkSoftwareData And AnalyticsHealth CareScience And EngineeringArtificial Intelligence
Aidoc, a leader in clinical AI, raised $150 million in Series E funding led by Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Investment Advisors, and NVentures. The funding will help scale Aidoc's enterprise AI platform to combat diagnostic errors. This round brings total funding to over $500 million. The investment underscores the growing demand for advanced clinical AI in healthcare.
Who to call at Aidoc, and when
A new round usually means Aidoc is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Aidoc raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Aidoc, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Aidoc
Location
New York, New York, United States
About
Aidoc is a global leader in clinical AI, offering the most FDA-cleared computer-aided detection (CAD) solutions on the market to support real-time clinical decision-making. Built on its proprietary Aidoc aiOS™, the platform integrates seamlessly into provider workflows to reduce cognitive load, improve productivity, and help clinicians prioritize cases with confidence across imaging and clinical data. Trusted by more than 1,600 medical centers worldwide, Aidoc powers care for over 60 million patients annually and enables health systems to scale clinical AI responsibly and effectively.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aidoc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.